B

Biofourmis

565 employees

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Personal Health
Remote Patient Management
Physiology Science
Cardiovascular
Physiology Monitoring
Artificial Intelligence
Post-acute Monitoring
Digital Health
mHealth
Oncology
Decentralized Clinical Trials
RPM
Digital Therapeutics
Therapeutics
Hybrid Clinical Trial
Predictive Analytics

Date founded

2015

Funding rounds raised

Total raised

$100M

from 12 investors over 12 rounds

B

Biofourmis raised $20M on July 27, 2022

Investors: Intel Capital

B

Biofourmis raised $100M on September 3, 2020

Investors: Openspace Ventures, EDBI Pte Ltd and SoftBank Investment Advisers

B

Biofourmis raised $35M on May 21, 2019

Investors: JIANKE.COM (健客), Openspace Ventures, EDBI Pte Ltd and SGInnovate

B

Biofourmis raised $2M on May 1, 2018

Investors: SGInnovate

B

Biofourmis raised $5M on December 11, 2017

Investors: Openspace Ventures

B

Biofourmis raised $1M on August 10, 2016

Investors: Eden Strategy Institute, LLP.

B

Biofourmis raised $71K on December 1, 2015

Investors: Eden Strategy Institute, LLP.

FAQ